JPH08131165A - New glycerol kinase and its production - Google Patents
New glycerol kinase and its productionInfo
- Publication number
- JPH08131165A JPH08131165A JP28042594A JP28042594A JPH08131165A JP H08131165 A JPH08131165 A JP H08131165A JP 28042594 A JP28042594 A JP 28042594A JP 28042594 A JP28042594 A JP 28042594A JP H08131165 A JPH08131165 A JP H08131165A
- Authority
- JP
- Japan
- Prior art keywords
- glycerol kinase
- glycerol
- flavobacterium
- kinase
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000057621 Glycerol kinases Human genes 0.000 title claims abstract description 62
- 108700016170 Glycerol kinases Proteins 0.000 title claims abstract description 61
- 238000004519 manufacturing process Methods 0.000 title claims description 19
- 230000000694 effects Effects 0.000 claims abstract description 28
- 241000589565 Flavobacterium Species 0.000 claims abstract description 16
- 241000894006 Bacteria Species 0.000 claims abstract description 13
- 241000589566 Elizabethkingia meningoseptica Species 0.000 claims abstract description 12
- 238000012258 culturing Methods 0.000 claims abstract description 7
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000003381 stabilizer Substances 0.000 claims description 5
- 101710163410 Probable glycerol kinase Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 abstract description 39
- 108090000790 Enzymes Proteins 0.000 abstract description 39
- 229940088598 enzyme Drugs 0.000 abstract description 39
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 abstract description 18
- 239000006228 supernatant Substances 0.000 abstract description 11
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 8
- 239000007853 buffer solution Substances 0.000 abstract description 7
- 238000004255 ion exchange chromatography Methods 0.000 abstract description 6
- 125000005456 glyceride group Chemical group 0.000 abstract description 5
- 235000019626 lipase activity Nutrition 0.000 abstract description 4
- 102000016943 Muramidase Human genes 0.000 abstract description 3
- 108010014251 Muramidase Proteins 0.000 abstract description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 abstract description 3
- 229940039227 diagnostic agent Drugs 0.000 abstract description 3
- 239000000032 diagnostic agent Substances 0.000 abstract description 3
- 239000004325 lysozyme Substances 0.000 abstract description 3
- 229960000274 lysozyme Drugs 0.000 abstract description 3
- 235000010335 lysozyme Nutrition 0.000 abstract description 3
- 238000011218 seed culture Methods 0.000 abstract description 3
- 230000002209 hydrophobic effect Effects 0.000 abstract description 2
- 239000000047 product Substances 0.000 abstract description 2
- 108091000080 Phosphotransferase Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 102000020233 phosphotransferase Human genes 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 60
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 28
- 239000000872 buffer Substances 0.000 description 15
- 238000000034 method Methods 0.000 description 15
- 238000010828 elution Methods 0.000 description 14
- 239000011780 sodium chloride Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 239000000758 substrate Substances 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 230000012010 growth Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- 229930195725 Mannitol Natural products 0.000 description 4
- 239000012614 Q-Sepharose Substances 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 239000000594 mannitol Substances 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 229960004793 sucrose Drugs 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000120652 Cellulomonas sp. Species 0.000 description 3
- 241000589589 Chryseobacterium indologenes Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000007990 PIPES buffer Substances 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000002525 ultrasonication Methods 0.000 description 3
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 2
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 description 2
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241000186063 Arthrobacter Species 0.000 description 2
- 241000186073 Arthrobacter sp. Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000589593 Chryseobacterium gleum Species 0.000 description 2
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 2
- -1 Citrate-malate-maleate-malonate-propionate Chemical compound 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 101710181606 Glycerol kinase 1 Proteins 0.000 description 2
- 108010041921 Glycerolphosphate Dehydrogenase Proteins 0.000 description 2
- 102000000587 Glycerolphosphate Dehydrogenase Human genes 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000589540 Pseudomonas fluorescens Species 0.000 description 2
- 241000607720 Serratia Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 108010046334 Urease Proteins 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 235000020299 breve Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 229940093496 esculin Drugs 0.000 description 2
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 2
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 125000001477 organic nitrogen group Chemical group 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- CIJQGPVMMRXSQW-UHFFFAOYSA-M sodium;2-aminoacetic acid;hydroxide Chemical compound O.[Na+].NCC([O-])=O CIJQGPVMMRXSQW-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PCTMTFRHKVHKIS-BMFZQQSSSA-N (1s,3r,4e,6e,8e,10e,12e,14e,16e,18s,19r,20r,21s,25r,27r,30r,31r,33s,35r,37s,38r)-3-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10 Chemical compound C1C=C2C[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2.O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 PCTMTFRHKVHKIS-BMFZQQSSSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LAVUIIQTSA-N (2R,3S,4R)-1-deuterio-2,3,4,5-tetrahydroxypentan-1-one Chemical compound [2H]C(=O)[C@H](O)[C@@H](O)[C@H](O)CO PYMYPHUHKUWMLA-LAVUIIQTSA-N 0.000 description 1
- XDIYNQZUNSSENW-NUVHGKSTSA-N (2r,3s,4s,5r)-2,3,4,5,6-pentahydroxyhexanal;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-NUVHGKSTSA-N 0.000 description 1
- GUBGYTABKSRVRQ-UIBZBYDUSA-N (3R,4R,5S,6R)-2-deuterio-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2,3,4-triol Chemical compound OC1([C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO)[2H] GUBGYTABKSRVRQ-UIBZBYDUSA-N 0.000 description 1
- PEDCQBHIVMGVHV-MICDWDOJSA-N 1-deuteriopropane-1,2,3-triol Chemical compound [2H]C(O)C(O)CO PEDCQBHIVMGVHV-MICDWDOJSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- GUPXYSSGJWIURR-UHFFFAOYSA-N 3-octoxypropane-1,2-diol Chemical compound CCCCCCCCOCC(O)CO GUPXYSSGJWIURR-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 241000186321 Cellulomonas Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241001595482 Columbicola bacillus Species 0.000 description 1
- SHZGCJCMOBCMKK-SVZMEOIVSA-N D-fucopyranose Chemical compound C[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O SHZGCJCMOBCMKK-SVZMEOIVSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241001058146 Erium Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589776 Pseudomonas putida Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000593950 Streptomyces canus Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 230000009603 aerobic growth Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- DVARTQFDIMZBAA-UHFFFAOYSA-O ammonium nitrate Chemical compound [NH4+].[O-][N+]([O-])=O DVARTQFDIMZBAA-UHFFFAOYSA-O 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- ULHPJBAQOMZNCP-UJPDDDSFSA-N ethanol;(2r,3s,4r)-2,3,4,5-tetrahydroxypentanal Chemical compound CCO.OC[C@@H](O)[C@H](O)[C@@H](O)C=O ULHPJBAQOMZNCP-UJPDDDSFSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000002795 fluorescence method Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000009229 glucose formation Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 108010054790 glycerol-3-phosphate oxidase Proteins 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- GFAZHVHNLUBROE-UHFFFAOYSA-N hydroxymethyl propionaldehyde Natural products CCC(=O)CO GFAZHVHNLUBROE-UHFFFAOYSA-N 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000003674 kinase activity assay Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 229950008679 protamine sulfate Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940120668 salicin Drugs 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000019086 sulfide ion homeostasis Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は70℃、10分間の熱処
理で80%以上の活性を保持することを特徴とするグリ
セロールキナーゼ(Glycerol kinase)
およびフラボバクテリウム(Flavobacteri
um)属に属するグリセロールキナーゼ生産菌を培地に
培養し、その培養物からグリセロールキナーゼを採取し
てなるグリセロールキナーゼの製造法に関する。FIELD OF THE INVENTION The present invention is characterized by retaining 80% or more of activity after heat treatment at 70 ° C. for 10 minutes.
And Flavobacterium
The present invention relates to a method for producing glycerol kinase, which comprises culturing a glycerol kinase-producing bacterium belonging to the genus um) in a medium and collecting glycerol kinase from the culture.
【0002】[0002]
【従来技術】グリセロールキナーゼはグリセロールを基
質としてグリセロール1モルおよびATP1モルから1
モルのADPおよび1モルのグリセロール−3−リン酸
を生成する反応を触媒する酵素(酵素番号2.7.1.
30)として知られており(酵素ハンドブック341〜
342頁、(株)朝倉書店、1982年発行)、また、
グリセロールキナーゼ生産菌としては従来からストレプ
トマイセス・キャナス(特開昭55−162987号公
報)、セルロモナス・エスピー(特開昭56−1214
84号公報)、バチルス・ステアロサーモフィラス(特
開昭53−26389号公報)、アルスロバクター・エ
スピー(特開昭59−2688号公報)などが知られて
おり、臨床診断薬の分野で使用されている。BACKGROUND ART Glycerol kinase uses glycerol as a substrate from 1 mol of glycerol and 1 mol of ATP to 1 mol.
An enzyme that catalyzes a reaction that produces moles of ADP and 1 mole of glycerol-3-phosphate (Enzyme No. 2.7.1.
30) (Enzyme Handbook 341-
Page 342, Asakura Shoten Co., Ltd., published in 1982)
As a glycerol kinase-producing bacterium, conventionally, Streptomyces canus (JP-A-55-162987) and Cellulomonas sp. (JP-A-56-1214) have been used.
84), Bacillus stearothermophilus (JP-A-53-26389), Arthrobacter sp. (JP-A-59-2688), and the like, and are in the field of clinical diagnostic agents. Used in.
【0003】また、本発明者らは臨床診断薬分野におい
て優れたグリセロールキナーゼをスクリーニングしたと
ころセラチア・マセセンス・IFO−3736株、シュ
ードモナス・フルオレッセンス・IFO−3925株、
シュードモナス・プチダ・IFO−12653株を後述
する参考例の培地にて培養したところ、それぞれ、0.
5U/ml、0.8U/ml、1.30U/mlの培養
力価でグリセロールキナーゼを生産することを見い出し
たが、いずれもKm値や熱安定性に優れるものではなか
った。Further, the present inventors have screened excellent glycerol kinases in the field of clinical diagnostics, and found that Serratia macesense IFO-3736 strain, Pseudomonas fluorescens IFO-3925 strain,
When the Pseudomonas putida IFO-12653 strain was cultured in the medium of Reference Example described later,
It was found that glycerol kinase was produced at a culture titer of 5 U / ml, 0.8 U / ml, and 1.30 U / ml, but none of them was excellent in Km value and thermostability.
【0004】[0004]
【発明が解決しようとする課題】グリセロールキナーゼ
は従来、臨床診断薬分野、例えばリパーゼまたはグリセ
リドの存在下にグリセロール−3−リン酸オキシダーゼ
やグリセロール−3−リン酸デヒドロゲナーゼと組み合
わせてグリセリドまたはリパーゼ活性の測定試薬に使用
され、その他同様の酵素反応によりグリセロールの測定
試薬などに使用されてきた。Glycerol kinases have traditionally been used in the field of clinical diagnostics, for example, in combination with glycerol-3-phosphate oxidase or glycerol-3-phosphate dehydrogenase in the presence of lipase or glyceride to detect glyceride or lipase activity. It has been used as a measuring reagent, and has also been used as a measuring reagent for glycerol by the same enzymatic reaction.
【0005】しかし、近年、臨床診断薬分野では試薬を
凍結乾燥品ではなく、液状で製品とすることが求められ
ており、液状化試薬に対応できるような保存安定性の優
れたグリセロールキナーゼや工業生産に対応できるよう
な熱安定性の優れたグリセロールキナーゼの開発が望ま
れていた。However, in recent years, in the field of clinical diagnostic agents, it has been required to make a reagent in a liquid state, not a freeze-dried state, and a glycerol kinase or an industrial product having excellent storage stability that can be used as a liquefied reagent. It has been desired to develop a glycerol kinase having excellent thermostability that can be used for production.
【0006】[0006]
【課題を解決するための手段】本発明者らは、熱安定性
が優れ、さらに、好適には液状化試薬に対応できる安定
性の優れたグリセロールキナーゼおよびその工業的生産
の可能な製造法を求めて鋭意研究を重ねた結果、静岡県
田方郡大仁町の畑土壌から単離したフラボバクテリウム
・メニンゴセプティクムGK−54株と同定した微生物
が安定性の優れたグリセロールキナーゼの生産能を有す
ることを初めて見いだし、本発明を完成した。[Means for Solving the Problems] The inventors of the present invention have identified a glycerol kinase having excellent thermostability and, more preferably, stability that can be applied to a liquefying reagent, and a production method capable of industrial production thereof. As a result of repeated earnest research, microorganisms identified as the Flavobacterium meningosepticum GK-54 strain isolated from the field soil of Ohi-cho, Takata-gun, Shizuoka Prefecture have excellent stability and are capable of producing glycerol kinase. The present invention has been completed for the first time by having found that
【0007】本発明は上記の知見に基づいて完成された
もので、70℃、10分の熱処理で80%以上の活性を
保持する熱安定性の良いグリセロールキナーゼ、また好
適には安定化剤を添加せず、37℃、2週間で80%以
上の活性を保持する保存安定性の良いグリセロールキナ
ーゼおよびフラボバクテリウム属に属するグリセロール
キナーゼ生産菌を培地に培養し、その培養物からグリセ
ロールキナーゼを採取することを特徴とするグリセロー
ルキナーゼの製造法である。The present invention has been completed based on the above findings, and a glycerol kinase having good thermostability, which retains 80% or more of activity by heat treatment at 70 ° C. for 10 minutes, and preferably a stabilizer. Without addition, glycerol kinase with good storage stability that retains 80% or more activity at 37 ° C for 2 weeks and glycerol kinase-producing bacteria belonging to the genus Flavobacterium are cultured in a medium, and glycerol kinase is collected from the culture. And a method for producing glycerol kinase.
【0008】以下に本発明について詳細に説明する。ま
ず、本発明のグリセロールキナーゼ生産菌について、フ
ラボバクテリウム属に属するグリセロールキナーゼを生
産する能力を有する微生物であれば何ら限定されるもの
ではなく、グリセロールキナーゼ生産能を有する変種や
変異株であってもよく、好ましくはフラボバクテリウム
属に属するGK−54株が挙げられる。本菌株の菌学的
性質を示すと次の通りである。Hereinafter, the present invention will be described in detail. First, the glycerol kinase-producing bacterium of the present invention is not limited at all as long as it is a microorganism having the ability to produce glycerol kinase belonging to the genus Flavobacterium, and it may be a variant or mutant strain having the ability to produce glycerol kinase. The GK-54 strain belonging to the genus Flavobacterium is preferable. The mycological properties of this strain are as follows.
【0009】なお、本菌株の同定に当たっては、同定実
験は医学細菌同定の手引(第2版)、Microbio
logical Methods(3巻)に準じて行
い、実験結果を医学細菌同定の手引(第2版)、Ber
gey’s Manual of Systemati
c Bacteriology Vol.1,Vol.
2,Vol.3、Int.J.Syst.Bacter
iologyに対比して同定を行った。In the identification of this strain, the identification experiment is a guide for identifying medical bacteria (2nd edition), Microbio.
The method was carried out in accordance with logical Methods (Vol. 3), and the experimental results were used as a guide for identifying medical bacteria (2nd edition), Ber.
gay's Manual of System
c Bacterology Vol. 1, Vol.
2, Vol. 3, Int. J. Syst. Bacter
Identification was performed in comparison with iology.
【0010】生育の特徴 普通寒天平板培地 線上に良好に生育する。表面は滑らか。縁は丸い。黄色
〜オレンジ色を呈する。不透明。光沢あり。 普通寒天斜面培地 線上に良好に生育する。表面は滑らか。縁は丸い。黄色
〜オレンジ色を呈する。不透明。光沢あり。 液体培地 生育良好で一様に生育する。 リトマスミルク培地およびBCP培地 リトマスを還元しないが、液化および凝固が観察され
た。 DNAのGCmol% 35.7±1.0%(HPLC) 主たるイソプレノイドキノン MK−6 形態の特徴 単独で端の丸いまっすぐな長桿菌で大きさは0.4〜
0.7X1.8〜2.5μm。運動性はない。芽胞非形
成。 生理、生化学的性状 グラム染色 − KOH反応テスト + 抗酸性染色 − OFテスト(Hugh−Leifson) 0 OFテスト(N源にNH4 H2 PO4 ) 0 好気での生育 + 嫌気での生育 − 生育温度12.3℃ − 16.0℃ + 40.4℃ + 43.6℃ − 至適温度は25〜39℃ 食塩耐性0% + 3.0% + 5.0% − 生育pH4.40 − 4.76 + 10.41 + 10.80 − 至適pHは7.5〜8.0 ゼラチン分解 + デンプン分解 − カゼイン分解 + エスクリン分解 + セルロース分解 − チロシン分解 − アルギニン分解 − Tween80分解 − カタラーゼ産生 + オキシダーゼ産生 + フォスファターゼ産生 + ウレアーゼ産生(SSR) − ウレアーゼ産生(Chris.) − インドール産生 − 硫化水素産生(TSI) − DNase産生 + アセトイン産生 − MRテスト − LV反応テスト − 硝酸塩還元テスト − 亜硝酸塩還元テスト + シモンズ培地での利用性 クエン酸塩 − リンゴ酸塩 − マレイン酸塩 − マロン酸塩 − プロピオン酸塩 − グルコン酸塩 − コハク酸塩 − クリステンゼン培地での利用性 クエン酸塩 (+) リンゴ酸塩 − マレイン酸塩 − マロン酸塩 − プロピオン酸塩 + グルコン酸塩 − コハク酸塩 − グルコースよりガス産生 − 糖より酸の産生 アドニトール − L(+)−アラビノース − セロビオース − ズルシトール − メソ−エリスリトール − フルクトース + D−フコース + D−ガラクトース − D−グルコース + グリセロール + イノシトール − イヌリン − ラクトース + マルトース + マンニトール + マンノース + メレジトース − メリビオース + ラフィノース − L(+)−ラムノース − D−リボース − サリシン − L−ソルボース − ソルビトール − スターチ + サッカロース − トレハロース + D−キシロース − エタノール(3%) + 色素の産生 フルオレッセンを産生 PHBの蓄積 − 無機窒素源の利用 硝酸塩 − アンモニウム塩 + 以上のように本菌株の主性状はグラム陰性の桿菌で非運
動性であり、カタラーゼ、オキシダーゼ、フォスファタ
ーゼ陽性でグルコースを酸化的に分解し、酸を産生し、
GCmol%は35.7±1.0%、キノンタイプはM
K−6、芽胞非形成であり、これらの主性状をBerg
ey’s Manual of Systematic
Bacteriology Vol.1,Vol.
2,Vol.3に対比した結果、フラボバクテリウム属
に属する微生物と判明した。そこで、フラボバクテリウ
ム属の中から本菌株と似た4菌種を選び本菌株と比較し
た。 A;フラボバクテリウム・ブレブ(Flavobact
erium breve)。 B;フラボバクテリウム・グレウム(Flavobac
terium gleum)。 C;フラボバクテリウム・インドロゲネス(Flavo
bacterium indologenes)。 D;フラボバクテリウム・メニンゴセプティクム(Fl
avobacterium meningosepti
cum)。Characteristics of growth Normal agar plate medium It grows well on a line. The surface is smooth. The edges are round. It exhibits a yellow to orange color. Opacity. There is gloss. Ordinary agar slope medium It grows well on the line. The surface is smooth. The edges are round. It exhibits a yellow to orange color. Opacity. There is gloss. Liquid medium Good growth and uniform growth. Litmus milk and BCP media Litmus was not reduced but liquefaction and coagulation were observed. GC mol% of DNA 35.7 ± 1.0% (HPLC) Characteristics of main isoprenoid quinone MK-6 morphology It is a long rod with a round end and a size of 0.4-
0.7 × 1.8 to 2.5 μm. There is no motility. No spore formation. Physiological and biochemical properties Gram stain-KOH reaction test + anti-acid stain-OF test (Hugh-Leifson) 0 OF test (NH 4 H 2 PO 4 for N source) 0 Aerobic growth + Anaerobic growth- Growth temperature 12.3 ° C-16.0 ° C + 40.4 ° C + 43.6 ° C- Optimum temperature is 25 to 39 ° C Salt tolerance 0% + 3.0% + 5.0%-Growth pH 4.40- 4.76 + 10.41 + 10.80- Optimal pH is 7.5-8.0 Gelatin decomposition + Starch decomposition-Casein decomposition + Esculin decomposition + Cellulose decomposition-Tyrosine decomposition-Arginine decomposition-Tween80 decomposition-Catalase production + Oxidase production + phosphatase production + urease production (SSR) -urease production (Chris.)-Indole production-hydrogen sulfide production ( TSI) -DNase production + acetoin production-MR test-LV reaction test-Nitrate reduction test-Nitrite reduction test + Availability in Simmons medium Citrate-malate-maleate-malonate-propionate -Gluconate-Succinate-Availability in Kristensen medium Citrate (+) Malate-Maleate-Malonate-Propionate + Gluconate-Succinate-Gas production from glucose -Production of acid from sugar Adonitol-L (+)-arabinose-cellobiose-dulcitol-meso-erythritol-fructose + D-fucose + D-galactose-D-glucose + glycerol + inositol-inulin-lactose + maltose + mannitol + mannitol. Sucrose + melezitose-melibiose + raffinose-L (+)-rhamnose-D-ribose-salicin-L-sorbose-sorbitol-starch + sucrose-trehalose + D-xylose-ethanol (3%) + pigment production fluorescein is produced. Accumulation of PHB-Use of inorganic nitrogen source Nitrate-Ammonium salt + As described above, the main characteristics of this strain are Gram-negative bacilli that are non-motile and positive for catalase, oxidase, and phosphatase, which oxidatively decompose glucose, Produces acid,
GC mol% is 35.7 ± 1.0%, quinone type is M
K-6, non-spore-forming, whose main characteristics are Berg
ey's Manual of Systematic
Bacteriology Vol. 1, Vol.
2, Vol. As a result of comparison with 3, the microorganism was found to belong to the genus Flavobacterium. Therefore, four strains similar to this strain were selected from the genus Flavobacterium and compared with this strain. A: Flavobacterium
erium breve). B: Flavobacterium gleum
terium gleum). C: Flavobacterium indologenes (Flavo
Bacterium indologenes). D: Flavobacterium meningosepticum (Fl
avobacterium meningosesepti
cum).
【0011】 A B C D 本菌 GC含量(%) 32.4 37.6 33.8 37.0 35.7 ±0.6 ±1.0 ±0.5 ±1.0 カゼイン分解 + + + + + エスクリン分解 − + + + + インドール産生 + + + d − 硝酸還元 − d − d − ウレアーゼ産生 − d − d − 5℃での生育 − − + − − 糖の資化性 グルコース + + + + + アラビノース − + − d − セロビオース − − − − − エタノール − − − d + フルクトース − + − d + グリセロール − d − d + ラクトース − − − d + マルトース d + + + + マンニトール − − − d + ラフィノース − − − − − サリシン − − − − − サッカロース − − − − − トレハロース − + − d + キシロース − d − − − (+:90%以上が陽性、d:11〜89%が陽性、−:90%以上が陰性) 性状の比較から本菌株はフラボバクテリウム・メニンゴ
セプティクムに属すると判断された。さらに、DNA−
DNAハイブリダイゼイション法によりDNA相同性
(similarity)測定を行った。測定方法はマ
イクロプレートを用いて蛍光法により分光光学的に定量
測定を行った。また、ハイブリダイゼイションの反応温
度はGC含量からDNAの融解温度を計算し40℃で行
った。比較対象として以下の菌株を用いて行った。 No.1株:フラボバクテリウム・ブレブIFO−14
93株:タイプカルチャー(Flavobacteri
um breveIFO−1493:タイプカルチャ
ー)。 No.2株:フラボバクテリウム・グレウムIFO−1
5054株:タイプカルチャー(Flavobacte
rium gleum IFO−15054:タイプカ
ルチャー)。 No.3株:フラボバクテリウム・インドロゲネスIF
O−14944株:タイプカルチャー(Flavoba
cterium indologenes IFO−1
4944:タイプカルチャー)。 No.4株:フラボバクテリウム・メニンゴセプティク
ムIFO−12535株:タイプカルチャー(Flav
obacterium meningosepticu
mIFO−12535:タイプカルチャー) 以上の結果から本菌株は、DNA相同性がフラボバクテ
リウム・メニンゴセプティクムIFO−12535株:
タイプカルチャー(F.meningosepticu
m IFO−12535:タイプカルチャー)と判断基
準である70%以上であることから前記知見と合わせて
同種と判定し、本菌株をフラボバクテリウム・メニンゴ
セプティクムGK−54株と同定命名し、工業技術院生
命工学技術研究所に受託番号FERM BP−4868
として寄託したものである。ABCD Main bacterium GC content (%) 32.4 37.6 33.8 37.0 35.7 ± 0.6 ± 1.0 ± 0.5 ± 1.0 Casein degradation + + + + + Esculin degradation − + + + + Indole production + + + d − Nitrate reduction − d − d − Urease production − d − d − 5 ° C. growth − − + − − Sugar assimilation glucose + + + + + Arabinose − + − d − cellobiose − − − − − ethanol − − − d + fructose − + − d + glycerol − d − d + lactose − − − d + maltose d + + + + + mannitol − − − d + raffinose −−−−− Salicin −−−−− Saccharose −−−−− Trehalose − + − d + xylose−d −−− (+: 90% or more positive, d: 1 1-89% is positive,-: 90% or more is negative) From the comparison of properties, it was determined that this strain belongs to Flavobacterium meningosepticum. In addition, DNA-
The DNA homology was measured by the DNA hybridization method. As a measuring method, quantitative measurement was performed spectroscopically by a fluorescence method using a microplate. The reaction temperature for hybridization was 40 ° C. by calculating the melting temperature of DNA from the GC content. The following strains were used for comparison. No. 1 strain: Flavobacterium bleb IFO-14
93 strains: type culture (Flavobacteri
um breve IFO-1493: type culture). No. 2 strains: Flavobacterium gureum IFO-1
5054 strain: type culture (Flavobacter
ium gleum IFO-15054: type culture). No. 3 strains: Flavobacterium indologenes IF
O-14944 strain: type culture (Flavova
cterium indologenes IFO-1
4944: Type culture). No. 4 strains: Flavobacterium meningosepticum IFO-12535 strains: type culture (Flav
Obacterium meningosepticu
mIFO-12535: Type Culture) From the above results, this strain has a DNA homology of Flavobacterium meningosepticum IFO-12535 strain:
Type culture (F. meningoseepticu
(m IFO-12535: type culture) and the determination criterion is 70% or more, so it was determined to be the same species together with the above findings, and this strain was identified and named Flavobacterium meningosepticum GK-54 strain. , Institute of Biotechnology, Institute of Industrial Science, contract number FERM BP-4868
Was deposited as.
【0012】次いで、フラボバクテリウム属に属するグ
リセロールキナーゼ生産菌からのグリセロールキナーゼ
の精製および、諸性質の検討を行った。本発明を実施す
るにあたり、その培養形態としては液体培養、個体培養
いずれも可能であるが工業的には通気撹拌培養を行うの
が有利である。また使用する培養源としては一般に微生
物培養に用いられる炭素源、窒素源、無機塩及びその他
の微量栄養源の他、フラボバクテリウム属に属する微生
物の利用できる栄養源であればすべて使用できる。Next, glycerol kinase was purified from a glycerol kinase-producing bacterium belonging to the genus Flavobacterium and various properties were examined. In carrying out the present invention, either liquid culture or solid culture can be used as the culture form, but industrially, aeration and agitation culture is advantageous. As a culture source to be used, in addition to carbon sources, nitrogen sources, inorganic salts and other trace nutrients generally used for culturing microorganisms, any nutrient source that can be utilized by a microorganism belonging to the genus Flavobacterium can be used.
【0013】炭素源としては、例えばグルコース、フル
クトース、サッカロース、キシロース、マルトース、グ
リセロール、デキストリン、でんぷん、アミノ酸等の
他、脂肪酸、油脂、有機酸などが単独でまたは組み合わ
せて用いられる。窒素源としては、例えば無機窒素源、
有機窒素源のいずれも使用可能であり、無機栄養源とし
ては硫酸アンモニウム、硝酸アンモニウム、尿素、硝酸
ソーダ、塩化アンモニウム等が挙げられる。また有機窒
素源としては、例えば大豆、米、トウモロコシ、小麦等
の粉、コーンスティープリカー、ペプトン、肉エキス、
カゼイン、アミノ酸、酵母エキス、バクトソイトン等が
挙げられる。As the carbon source, for example, glucose, fructose, sucrose, xylose, maltose, glycerol, dextrin, starch, amino acids, etc., as well as fatty acids, oils and fats, organic acids, etc. may be used alone or in combination. As the nitrogen source, for example, an inorganic nitrogen source,
Any organic nitrogen source can be used, and examples of the inorganic nutrient source include ammonium sulfate, ammonium nitrate, urea, sodium nitrate, ammonium chloride and the like. As the organic nitrogen source, for example, soybean, rice, corn, flour such as wheat, corn steep liquor, peptone, meat extract,
Examples include casein, amino acids, yeast extract, bacto soyton and the like.
【0014】無機塩及び微量栄養素としては、例えばリ
ン酸、マグネシュウム、カリウム、鉄、カルシウム、亜
鉛等の塩類の他ビタミン、非イオン性界面活性剤、消泡
剤等の菌の生育やグリセロールキナーゼの生産を促進す
るものであれば必要に応じて使用できる。培養は好気的
条件で、培養温度は菌が発育し、グリセロールキナーゼ
が産生する範囲であればよく、通常15℃〜37℃、好
ましくは25℃〜35℃である。培養時間は条件により
異なるがグリセロールキナーゼが最も産生される時間ま
で培養すればよく、通常24〜100時間程度である。Examples of inorganic salts and micronutrients include salts such as phosphoric acid, magnesium, potassium, iron, calcium and zinc, as well as growth of bacteria such as vitamins, nonionic surfactants and defoamers, and glycerol kinase. Any material that promotes production can be used as needed. The culture is carried out under aerobic conditions, and the culture temperature may be in the range where the bacteria grow and glycerol kinase is produced, and is usually 15 ° C to 37 ° C, preferably 25 ° C to 35 ° C. The culturing time varies depending on the conditions, but it may be cultivated until the time when glycerol kinase is most produced, and is usually about 24 to 100 hours.
【0015】グリセロールキナーゼは主としてその菌体
内に含有、蓄積されており、その菌体内から抽出すれば
よい。グリセロールキナーゼの抽出法を例示すればまず
培養物を固液分離し、得られた湿潤菌体をリン酸緩衝液
やトリス−塩酸緩衝液などの溶液に分散し、リゾチーム
処理、超音波処理、フレンチプレス処理、ダイノミル処
理などの種々の菌体処理手段を適宜選択組み合わせて、
粗製のグリセロールキナーゼ含有液を得る。Glycerol kinase is mainly contained and accumulated in the cells, and it may be extracted from the cells. As an example of the extraction method of glycerol kinase, the culture is first subjected to solid-liquid separation, the obtained wet cells are dispersed in a solution such as a phosphate buffer solution or a Tris-hydrochloric acid buffer solution, lysozyme treatment, ultrasonic treatment, and French treatment. By appropriately selecting and combining various bacterial cell treatment means such as press treatment and dynomill treatment,
A crude glycerol kinase containing solution is obtained.
【0016】粗製のグリセロールキナーゼ含有液から公
知のタンパク質や酵素などの単離、精製手段を用いて精
製グリセロールキナーゼを得る。例えば、粗製のグリセ
ロールキナーゼ含有液にアセトン、メタノール、エタノ
ールなどの有機溶媒による分別沈澱法、硫安、食塩など
による塩析法などを適用してグリセロールキナーゼを沈
澱させ、回収する。Purified glycerol kinase is obtained from the crude glycerol kinase-containing liquid by a known means for isolating and purifying proteins and enzymes. For example, glycerol kinase is precipitated and recovered by applying a fractional precipitation method using an organic solvent such as acetone, methanol, and ethanol, a salting-out method using ammonium sulfate, sodium chloride, etc. to a crude glycerol kinase-containing liquid.
【0017】さらに、この沈澱物を必要に応じ透析、等
電点沈澱を行った後、電気泳動法などで単一の帯を示す
まで、イオン交換体、ゲル濾過剤、吸着体などを用いる
カラムクロマトグラフィーなどにより精製する。また、
これらの方法を適当に組み合わせることによりグリセロ
ールキナーゼの精製度が上がる場合は適宜組み合わせて
行うことができる。Further, after subjecting this precipitate to dialysis and isoelectric point precipitation as needed, a column using an ion exchanger, a gel filter, an adsorbent, etc. until a single band is shown by electrophoresis or the like. Purify by chromatography or the like. Also,
When the purification degree of glycerol kinase is improved by appropriately combining these methods, they can be appropriately combined.
【0018】これらの方法によって得られる酵素は安定
化剤として、各種の塩類、糖類、タンパク質、脂質、界
面活性剤などを加えあるいは加える事なく、限外濾過濃
縮、凍結乾燥の方法により、液状または固形のグリセロ
ールキナーゼを得ることができ、また、適宜凍結乾燥を
行ってもよく、この場合安定化剤としてサッカロース、
マンニトール、食塩、アルブミンなどを0.5〜10%
程度添加してもよい。The enzyme obtained by these methods can be used as a stabilizer in a liquid form or by a method of ultrafiltration concentration and lyophilization without or with addition of various salts, saccharides, proteins, lipids, surfactants and the like. Solid glycerol kinase can be obtained, and may be appropriately lyophilized. In this case, sucrose as a stabilizer,
0.5-10% mannitol, salt, albumin, etc.
You may add about.
【0019】つぎに本発明で得られるグリセロールキナ
ーゼの理化学的性質及び酵素活性測定法を述べる。 グリセロールキナーゼの活性測定法 0.2Mのトリス−塩酸緩衝液(pH8.0)を0.2
ml、5%のグリセロールを0.1ml、0.1MのA
TPを0.02ml、0.1MのMgCl2を0.04
ml、45U/mlのペルオキシダーゼ(シグマ社製)
を0.1ml、0.3%の4−アミノアンチピリンを
0.1ml、0.25%のフェノールを0.1ml、1
00U/mlのグリセロホスフェイトオキシダーゼ(旭
化成社製)を0.2ml、および蒸留水を0.14ml
よりなる反応液1mlを37℃で1分間予備加温した
後、0.02mlの酵素液を添加して10分間反応させ
る。反応後、0.5%のSDSを2ml添加して反応を
停止させ、5分以内に層長1cmセルを用いて波長50
0nmにおける吸光度を測定する(As)。また、盲検
として酵素液のかわりに蒸留水0.02mlを用いて同
一の操作を行って吸光度を測定する(Ab)、この酵素
液使用の吸光度(As)と盲検の吸光度(Ab)の吸光
度差(As−Ab)より酵素活性を求める。酵素活性1
単位は37℃で1分間に1μモルのグリセロホスフェイ
トを生成させる酵素量とし、計算式は下記の通りであ
る。Next, the physicochemical properties of glycerol kinase obtained by the present invention and the method for measuring enzyme activity will be described. Glycerol kinase activity assay 0.2 M Tris-HCl buffer (pH 8.0) 0.2
ml, 5% glycerol 0.1 ml, 0.1M A
TP 0.02 ml, 0.1M MgCl 2 0.04
ml, 45 U / ml peroxidase (manufactured by Sigma)
0.1 ml, 0.3% 4-aminoantipyrine 0.1 ml, 0.25% phenol 0.1 ml, 1
0.2 ml of 00 U / ml glycerophosphate oxidase (manufactured by Asahi Kasei) and 0.14 ml of distilled water
After preliminarily heating 1 ml of the resulting reaction solution at 37 ° C. for 1 minute, 0.02 ml of the enzyme solution is added and reacted for 10 minutes. After the reaction, the reaction was stopped by adding 2 ml of 0.5% SDS, and within 5 minutes, a cell having a layer length of 1 cm was used and a wavelength of 50 was used.
The absorbance at 0 nm is measured (As). Further, as a blind test, the absorbance is measured by performing the same operation using 0.02 ml of distilled water instead of the enzyme solution (Ab). The absorbance (As) using this enzyme solution and the blind absorbance (Ab) are used. The enzyme activity is determined from the difference in absorbance (As-Ab). Enzyme activity 1
The unit is the amount of enzyme that produces 1 μmol of glycerophosphate per minute at 37 ° C., and the calculation formula is as follows.
【0020】[0020]
【数1】 [Equation 1]
【0021】理化学的性質 (1)酵素作用:基質としてグリセロールを用いた酵素
作用を以下に示す。Physicochemical properties (1) Enzyme action: The enzyme action using glycerol as a substrate is shown below.
【0022】[0022]
【化1】 Embedded image
【0023】(2)基質特異性:グリセロールに基質特
異性を示す。各種基質に対する特異性は表1の通りであ
る。(2) Substrate specificity: shows substrate specificity for glycerol. The specificity for various substrates is shown in Table 1.
【0024】[0024]
【表1】 [Table 1]
【0025】(3)Km値:3.9x10-2±0.5x
10-2mM(グリセロールに対して)、5.3x10-2
±0.5x10-2mM(ATPに対して) (4)等電点:4.4±0.5(キャリアー−アンホラ
インを用いた電気泳動法にて) (5)分子量:145000±5000(TSK G−
3000SWによるゲル濾過法にて)、50000±5
000(SDSポリアクリルアミドゲル電気泳動法に
て) (6)至適pH 前記酵素活性測定法にしたがって至適pHを求めたもの
で、その結果を図1に示した。pH4.5〜6.5の範
囲は100mMのクエン酸緩衝液、pH5.5〜7.5
の範囲は100mMのBis−Tris緩衝液、pH
6.5〜7.5の範囲は100mMのリン酸緩衝液、p
H7.0〜8.5の範囲は100mMのトリス−塩酸緩
衝液、pH8.5〜11.0の範囲は100mMのグリ
シン−水酸化ナトリウム緩衝液を使用した場合の活性値
を示すもので、至適pHは7.5〜8であった。 (7)pH安定性 100mM各種緩衝液(グリセロールキナーゼ1U/m
l)を37゜C、60分間処理し、その残存活性を前記
酵素活性測定法に従って測定した。その結果を図2に示
す。pH0.5〜4.0は100mMのクラークアンド
ルブス緩衝液、pH3.5〜7.0は100mMの酢酸
緩衝液、pH6.5〜8.0は100mMのリン酸緩衝
液、pH8.0〜9.0は100mMのトリス−塩酸緩
衝液、pH9.0〜11.0は100mMのグリシン−
水酸化ナトリウム緩衝液を使用した。pH3〜11の範
囲で最も良好な安定性を示した。 (8)至適温度 前記酵素活性測定法に従って、温度を37゜C〜95゜
Cの範囲で変化させて至適温度を求めた結果は図3に示
すとおりであり、本酵素の至適温度は80゜Cであっ
た。 (8)熱安定性 100mMトリス−塩酸緩衝液(pH 8.0)(グリ
セロールキナーゼ1U/ml)を各温度で10分間加熱
処理した後の残存活性を前記酵素活性測定法に従って測
定した。その結果、図4に示すとおり少なくとも60゜
Cまで100%安定で、70℃、10分間の処理では8
0%以上の残存活性を保持していた。 (9)金属イオンの影響 各種金属イオン(1mM)の本酵素活性への影響につい
て調べた結果は表2に示すとおりで、カルシウムイオン
による弱い阻害がみられた。(3) Km value: 3.9x10 -2 ± 0.5x
10 -2 mM (relative to glycerol) 5.3 x 10 -2
± 0.5 × 10 -2 mM (relative to ATP) (4) Isoelectric point: 4.4 ± 0.5 (by electrophoresis using carrier-ampholine) (5) Molecular weight: 145000 ± 5000 (TSK G-
(By gel filtration method with 3000SW), 50,000 ± 5
000 (by SDS polyacrylamide gel electrophoresis) (6) Optimum pH The optimum pH was determined according to the enzyme activity measuring method described above, and the results are shown in FIG. The pH range of 4.5 to 6.5 is 100 mM citrate buffer, pH 5.5 to 7.5.
Range is 100 mM Bis-Tris buffer, pH
The range of 6.5 to 7.5 is 100 mM phosphate buffer, p
The range of H7.0 to 8.5 is 100 mM Tris-hydrochloric acid buffer solution, and the range of pH 8.5 to 11.0 is the activity value when 100 mM glycine-sodium hydroxide buffer solution is used. The suitable pH was 7.5-8. (7) pH stability 100 mM various buffers (glycerol kinase 1 U / m
l) was treated at 37 ° C. for 60 minutes, and its residual activity was measured according to the above-mentioned enzyme activity measuring method. The result is shown in FIG. pH 0.5-4.0 is 100 mM Clark Andrus buffer, pH 3.5-7.0 is 100 mM acetate buffer, pH 6.5-8.0 is 100 mM phosphate buffer, pH 8.0-9. 0.0 is 100 mM Tris-HCl buffer, pH 9.0-11.0 is 100 mM glycine-
Sodium hydroxide buffer was used. The best stability was shown in the pH range of 3-11. (8) Optimum temperature The optimum temperature was determined according to the method for measuring enzyme activity by changing the temperature in the range of 37 ° C to 95 ° C as shown in Fig. 3. Was 80 ° C. (8) Thermostability 100 mM Tris-hydrochloric acid buffer solution (pH 8.0) (glycerol kinase 1 U / ml) was heat-treated at each temperature for 10 minutes, and the residual activity was measured according to the above-mentioned enzyme activity measuring method. As a result, as shown in Fig. 4, it is 100% stable up to at least 60 ° C, and is 8 at 10 ° C for 10 minutes.
It retained a residual activity of 0% or more. (9) Effect of metal ion The results of examining the effect of various metal ions (1 mM) on the activity of this enzyme are shown in Table 2, and weak inhibition by calcium ion was observed.
【0026】[0026]
【表2】 [Table 2]
【0027】(10)N末端アミノ酸配列 Met−Asp−Glu−Lys−Leu−Ile−L
eu−Ala−Leu−Asp−Glu−Gly−Th
r−Thr− (11)保存安定性 液状化試薬の対応を目的として、0.05%のNaN3
(防腐剤)を含む、20mMのトリス−塩酸緩衝液(p
H7.5)に、本発明グリセロールを0.8U/mlの
濃度となるように調製し、37℃で2日後、1週間後、
2週間後、3週間後、4週間後に残存活性を前記活性測
定法で測定した結果、それぞれ、94%、91%、81
%、71%、60%の活性を保持していた。このことか
ら、本酵素は安定化剤(例えばBSAや糖類)の非存在
下、37℃、2週間で80%以上の活性を保持してい
た。(10) N-terminal amino acid sequence Met-Asp-Glu-Lys-Leu-Ile-L
eu-Ala-Leu-Asp-Glu-Gly-Th
r-Thr- (11) Storage stability For the purpose of dealing with a liquefaction reagent, 0.05% NaN 3
20 mM Tris-HCl buffer (p) containing (preservative)
H7.5), the glycerol of the present invention was prepared to a concentration of 0.8 U / ml, and after 2 days at 37 ° C. and 1 week later,
After 2 weeks, 3 weeks, and 4 weeks, the residual activity was measured by the above-mentioned activity measurement method, and the results were 94%, 91%, and 81%, respectively.
%, 71% and 60% of the activity was retained. From this, this enzyme retained 80% or more activity at 37 ° C. for 2 weeks in the absence of a stabilizer (eg, BSA or saccharide).
【0028】以上の結果から、本発明グリセロールキナ
ーゼと従来から知られているグリセロールキナーゼとの
性質を比較すると、次のようになる。 (ATPに対するKm値) 本酵素:0.053mM ストレプトマイセス・キャナス由来:0.2mM セルロモナス・エスピー由来:0.43mM アルスロバクター・アルトロシアネウス由来:3.7m
M (熱安定性) 本酵素:70℃10分間の熱処理で80%以上の活性を
保持していた。From the above results, the properties of the glycerol kinase of the present invention and the conventionally known glycerol kinase are compared as follows. (Km value for ATP) This enzyme: 0.053 mM Streptomyces canas origin: 0.2 mM Cellulomonas sp. Origin: 0.43 mM Arthrobacter altranyaneus origin: 3.7 m
M (Thermal stability) The present enzyme: 80% or more of activity was retained by heat treatment at 70 ° C for 10 minutes.
【0029】セルロモナス・キャナス由来:pH7.
5、45℃、15分間の処理で、96%の残存活性を保
持する。70℃の処理では完全に失活する。 アルスロバクター・アルトロシアネウス由来:pH7.
0、15分間の処理で45℃以下の温度で安定。 バチルス・ステアロサーモフィラス由来:65℃、10
分間の熱処理で10%の残存活性であった(図5)。 (至適温度) 本酵素:80℃ セルロモナス・エスピー由来:50℃付近 アルスロバクター・エスピー由来:50℃付近 バチルス・ステアロサーモフィラス由来:65℃±5℃ 上記のように本発明グリセロールキナーゼは従来より知
られている酵素とは明かに異なる性質を持っており、特
に熱安定性に関しては最も優れた安定性を保持してい
た。Derived from Cellulomonas canus: pH 7.
Treatment at 5, 45 ° C. for 15 minutes retains 96% residual activity. It is completely deactivated by the treatment at 70 ° C. Derived from Arthrobacter Altorianius: pH 7.
Stable at a temperature of 45 ° C or lower after treatment for 0 to 15 minutes. From Bacillus stearothermophilus: 65 ° C, 10
After the heat treatment for 1 minute, the residual activity was 10% (FIG. 5). (Optimal temperature) This enzyme: 80 ° C. Cellulomonas sp. Origin: around 50 ° C. Arthrobacter sp. Origin: around 50 ° C. Bacillus stearothermophilus origin: 65 ° C. ± 5 ° C. The glycerol kinase of the present invention as described above Has a distinctly different property from the conventionally known enzymes, and has the most excellent thermal stability in particular.
【0030】[0030]
【実施例】ついで、本発明の実施例を詳しく述べるが、
本発明は何らこれにより限定されるものではない。EXAMPLES Next, examples of the present invention will be described in detail.
The present invention is not limited to this.
【0031】[0031]
【実施例1】フラボバクテリウム・メニンゴセプティク
ムGK−54株を1.0%のグリセロール、3.0%の
肉エキス、0.5%のバクトソイトン(ディフコ社製)
からなる培地(pH7.0)を500mlの三角フラス
コに150mlずつ分注したものに植菌した後、28
℃、30時間培養を行い、種培養液を得た。Example 1 Flavobacterium meningosepticum GK-54 strain was prepared by adding 1.0% glycerol, 3.0% meat extract, and 0.5% bactoisoton (manufactured by Difco).
After inoculating the medium (pH 7.0) consisting of 150 ml into a 500 ml Erlenmeyer flask, 28
Culturing was performed at 30 ° C. for 30 hours to obtain a seed culture solution.
【0032】種培養液を上記と同一組成培地に消泡剤を
加えた培地(pH7.0)20lのジャーファーメンタ
ー4基にそれぞれ2本ずつ添加し、28℃で22時間培
養した。培養終了後、培養物を4000rpmで遠心
し、菌体3.0Kgを回収した。この菌体に10mMの
EDTA、0.3%のトリトンX−100、20mMの
トリス−塩酸緩衝液(pH8.6)を含む、0.1%の
リゾチーム溶液9lを加え、37℃で90分間反応させ
て可溶化を行った。その後、これを4000rpmで2
0分間遠心し、不溶物を除去してその上清9l(720
00U)を得た。Two seed cultures were added to each of four 20 l jar fermenters in a medium (pH 7.0) containing an antifoaming agent in the same composition medium as above, and cultured at 28 ° C. for 22 hours. After completion of the culture, the culture was centrifuged at 4000 rpm to collect 3.0 Kg of bacterial cells. To the cells, 9 l of 0.1% lysozyme solution containing 10 mM EDTA, 0.3% Triton X-100 and 20 mM Tris-hydrochloric acid buffer (pH 8.6) was added, and the mixture was reacted at 37 ° C for 90 minutes. And solubilized. Then, this is 2 at 4000 rpm.
Centrifuge for 0 minutes to remove insoluble matter and remove the supernatant 9 l (720
00U) was obtained.
【0033】ついでこの上清に5.0%の硫酸プロタミ
ン90mlを加えて沈澱物を遠心除去し、さらにその上
清を50℃で30分間加熱し、沈澱物を遠心除去した。
その遠心上清を20mMのトリス−塩酸緩衝液(pH
7.5)にて一夜透析し、Q−セファロース(2.7×
30cm)(ファルマシア社製)イオン交換クロマトグ
ラフィーを行った。溶出は塩化ナトリウムの0〜0.5
Mのリニアグラジエントにより行い、0.2〜0.3M
の塩化ナトリウム溶出画分(29000U)を回収し
た。Next, 90 ml of 5.0% protamine sulfate was added to the supernatant to remove the precipitate by centrifugation, and the supernatant was heated at 50 ° C. for 30 minutes to remove the precipitate by centrifugation.
The centrifugation supernatant was treated with 20 mM Tris-HCl buffer (pH
7.5) overnight dialysis, Q-Sepharose (2.7 x
30 cm) (Pharmacia) ion exchange chromatography was performed. Elution is 0 to 0.5 of sodium chloride
0.2 to 0.3M with a linear gradient of M
The sodium chloride elution fraction (29000 U) was collected.
【0034】この酵素溶液に2.5Mの濃度となるよう
に塩化ナトリウムを溶解し、オクチルセファロース
(2.6×20cm)(ファルマシア社製)の疎水クロ
マトグラフィーを行った。溶出は2.5M〜0Mの塩化
ナトリウムのリニアグラジエントにより行い、0Mの塩
化ナトリウムの溶出画分(25000U)を回収した。
ついでこの酵素液を20mMのトリス−塩酸緩衝液(p
H7.5)にて一夜透析し、ハイドロキシアパタイト
(1.6×26.5cm)(ペンタックス社製)クロマ
トグラフィーを行った。溶出は5〜0.2Mのリン酸緩
衝液によるリニアグラジエントにより行い、0.1〜
0.12Mのリン酸緩衝液の溶出画分(16300U)
を回収した。Sodium chloride was dissolved in this enzyme solution to a concentration of 2.5 M, and octyl sepharose (2.6 × 20 cm) (manufactured by Pharmacia) was subjected to hydrophobic chromatography. Elution was performed with a linear gradient of 2.5 M to 0 M sodium chloride, and an elution fraction of 0 M sodium chloride (25000 U) was collected.
Then, this enzyme solution was added to 20 mM Tris-HCl buffer (p
It was dialyzed against H7.5) overnight and subjected to hydroxyapatite (1.6 × 26.5 cm) (Pentax) chromatography. Elution is performed with a linear gradient of 5-0.2 M phosphate buffer,
Elution fraction of 0.12 M phosphate buffer (16300 U)
Was recovered.
【0035】ついでこの酵素液を20mMのトリス−塩
酸緩衝液(pH7.5)にて一夜透析し、DEAE−セ
ファロース(1.6×20cm)(ファルマシア社製)
イオン交換クロマトグラフィーを行った。溶出は0〜
0.5Mの塩化ナトリウムによるリニアグラジエントに
より行い、0.2〜0.3Mの塩化ナトリウムの溶出画
分(12000U)を回収し、20mMのトリス−塩酸
緩衝液(pH7.5)に一夜透析後、BSAを1%とな
るように添加して、凍結乾燥し、精製グリセロールキナ
ーゼ(12000U、9.9U/mg)を得た。Then, the enzyme solution was dialyzed against 20 mM Tris-hydrochloric acid buffer solution (pH 7.5) overnight, and DEAE-Sepharose (1.6 × 20 cm) (Pharmacia).
Ion exchange chromatography was performed. Elution is 0
Performed by a linear gradient with 0.5 M sodium chloride to collect an elution fraction of 0.2 to 0.3 M sodium chloride (12000 U), dialyzed against 20 mM Tris-hydrochloric acid buffer (pH 7.5) overnight, BSA was added to 1% and freeze-dried to obtain purified glycerol kinase (12000U, 9.9U / mg).
【0036】このようにして得られたグリセロールキナ
ーゼの理化学的性質は前記した通りである。The physicochemical properties of the glycerol kinase thus obtained are as described above.
【0037】[0037]
【参考例1】セラチア・マセセンス・IFO−3736
株を2.0%のグリセロール、2.0%の酵母エキスか
らなる培地(pH7.0)を500mlの三角フラスコ
に150mlずつ分注したものに植菌した後、28℃、
30時間培養を行った。培養終了後、培養物を8000
rpmで遠心し、菌体30mgを回収した。得られた菌
体を10mMのトリス−塩酸緩衝液(pH7.5)30
mlに懸濁し、超音波破砕によって可溶化を行った。[Reference Example 1] Serratia macesense IFO-3736
The strain was inoculated into a 500 ml Erlenmeyer flask in which 150 ml of a medium (pH 7.0) consisting of 2.0% glycerol and 2.0% yeast extract was inoculated, and at 28 ° C.
Culture was performed for 30 hours. After completing the culture,
Centrifugation was carried out at rpm to collect 30 mg of bacterial cells. The obtained cells were treated with 10 mM Tris-hydrochloric acid buffer solution (pH 7.5) 30
It was suspended in ml and solubilized by ultrasonication.
【0038】その後、可溶化液を16000rpmで遠
心し、不溶物を除去した上清29ml(70U)を得
た。次いで、遠心上清を8lの10mMのトリス−塩酸
緩衝液に一夜、透析した後、Q−セファロース(2x8
cm)(ファルマシア社製)イオン交換クロマトグラフ
ィーを行った。溶出は塩化ナトリウムの0〜0.5Mの
リニアグラジエントにより行い、0.2〜0.3Mの塩
化ナトリウム溶出画分(67U)を回収し、粗製グリセ
ロールキナーゼ(67U、25U/mg)を得た。 理化学的性質 (1)酵素作用および基質特異性:グリセロールに対す
る本酵素の酵素作用および基質特異性はフラボバクテリ
ウム・メニンゴセプティクムGK−54(FERM B
P−4868)株と同じであった。 (2)Km値:2.4x10-2±0.5x10-2mM
(グリセロールに対して)、5.0x10-1±0.5x
10-1mM(ATPに対して) (3)至適pH:7.5(50mMのPIPES緩衝
液)Then, the solubilized solution was centrifuged at 16000 rpm to obtain 29 ml (70 U) of a supernatant in which insoluble matter was removed. The centrifuged supernatant was then dialyzed against 8 l of 10 mM Tris-HCl buffer overnight, followed by Q-Sepharose (2x8).
cm) (Pharmacia) ion exchange chromatography was performed. Elution was performed with a 0 to 0.5 M linear gradient of sodium chloride, and a 0.2 to 0.3 M sodium chloride elution fraction (67 U) was collected to obtain crude glycerol kinase (67 U, 25 U / mg). Physicochemical properties (1) Enzyme action and substrate specificity: The enzyme action and substrate specificity of this enzyme for glycerol are flavobacterium meningosepticum GK-54 (FERM B
P-4868) strain. (2) Km value: 2.4x10 -2 ± 0.5x10 -2 mM
(Relative to glycerol), 5.0x10 -1 ± 0.5x
10 -1 mM (relative to ATP) (3) Optimum pH: 7.5 (50 mM PIPES buffer)
【0039】[0039]
【参考例2】シュードモナス・フルオレッセンス・IF
O−3925株を2.0%のグリセロール、2.0%の
酵母エキスからなる培地(pH7.0)を500mlの
三角フラスコに150mlずつ分注したものに植菌した
後、28℃、30時間培養を行った。[Reference example 2] Pseudomonas fluorescens IF
The O-3925 strain was inoculated into a 500 ml Erlenmeyer flask in which 150 ml of a medium (pH 7.0) consisting of 2.0% glycerol and 2.0% yeast extract was inoculated, and then at 28 ° C. for 30 hours. Culture was performed.
【0040】培養終了後、培養物を8000rpmで遠
心し、菌体30mgを回収した。得られた菌体を10m
Mのトリス−塩酸緩衝液(pH7.5)30mlに懸濁
し、超音波破砕によって可溶化を行った。その後、可溶
化液を16000rpmで遠心し、不溶物を除去した上
清29ml(130U)を得た。次いで、遠心上清を8
lの10mMのトリス−塩酸緩衝液に一夜、透析した
後、Q−セファロース(2x8cm)(ファルマシア社
製)イオン交換クロマトグラフィーを行った。溶出は塩
化ナトリウムの0〜0.5Mのリニアグラジエントによ
り行い、0.2〜0.3Mの塩化ナトリウム溶出画分
(114U)を回収し、粗製グリセロールキナーゼ(1
14U、30U/mg)を得た。 理化学的性質 (1)酵素作用および基質特異性:グリセロールに対す
る本酵素の酵素作用および基質特異性はフラボバクテリ
ウム・メニンゴセプティクムGK−54(FERM B
P−4868)株と同じであった。 (2)Km値:2.0x10-2±0.5x10-2mM
(グリセロールに対して)、2.4±0.5mM(AT
Pに対して) (3)至適pH:7.5(50mMのPIPES緩衝
液)After the completion of the culture, the culture was centrifuged at 8000 rpm to recover 30 mg of bacterial cells. 10m of the obtained fungus body
It was suspended in 30 ml of M Tris-hydrochloric acid buffer (pH 7.5) and solubilized by ultrasonication. Then, the solubilized solution was centrifuged at 16000 rpm to obtain 29 ml (130 U) of a supernatant in which insoluble matter was removed. Then, centrifuge the supernatant 8 times.
After dialysis against 1 l of 10 mM Tris-HCl buffer overnight, Q-sepharose (2 × 8 cm) (Pharmacia) ion exchange chromatography was performed. Elution was performed with a 0 to 0.5 M linear gradient of sodium chloride, and a 0.2 to 0.3 M sodium chloride elution fraction (114 U) was collected, and the crude glycerol kinase (1
14 U, 30 U / mg) was obtained. Physicochemical properties (1) Enzyme action and substrate specificity: The enzyme action and substrate specificity of this enzyme for glycerol are flavobacterium meningosepticum GK-54 (FERM B
P-4868) strain. (2) Km value: 2.0x10 -2 ± 0.5x10 -2 mM
2.4 ± 0.5 mM (for glycerol) (AT
(For P) (3) Optimum pH: 7.5 (50 mM PIPES buffer)
【0041】[0041]
【参考例3】シュードモナス・プチダ・IFO−126
53株を2.0%のグリセロール、2.0%の酵母エキ
スからなる培地(pH7.0)を500mlの三角フラ
スコに150mlずつ分注したものに植菌した後、28
℃、30時間培養を行った。培養終了後、培養物を80
00rpmで遠心し、菌体30mgを回収した。得られ
た菌体を10mMのトリス−塩酸緩衝液(pH7.5)
30mlに懸濁し、超音波破砕によって可溶化を行っ
た。その後、可溶化液を16000rpmで遠心し、不
溶物を除去した上清29ml(190U)を得た。[Reference Example 3] Pseudomonas Puchida IFO-126
The 53 strain was inoculated into a 500 ml Erlenmeyer flask in which 150 ml of a medium (pH 7.0) consisting of 2.0% glycerol and 2.0% yeast extract was inoculated.
Culturing was performed at 30 ° C. for 30 hours. After completion of the culture,
The cells were centrifuged at 00 rpm to collect 30 mg of the bacterial cells. The obtained cells were treated with 10 mM Tris-HCl buffer (pH 7.5).
It was suspended in 30 ml and solubilized by ultrasonication. Then, the solubilized solution was centrifuged at 16000 rpm to obtain 29 ml (190 U) of a supernatant in which insoluble matter was removed.
【0042】次いで、遠心上清を8lの10mMのトリ
ス−塩酸緩衝液に一夜、透析した後、Q−セファロース
(2x8cm)(ファルマシア社製)イオン交換クロマ
トグラフィーを行った。溶出は塩化ナトリウムの0〜
0.5Mのリニアグラジエントにより行い、0.2〜
0.3Mの塩化ナトリウム溶出画分(110U)を回収
し、粗製グリセロールキナーゼ(110U、30U/m
g)を得た。 理化学的性質 (1)酵素作用および基質特異性:グリセロールに対す
る本酵素の酵素作用および基質特異性はフラボバクテリ
ウム・メニンゴセプティクムGK−54(FERM B
P−4868)株と同じであった。 (2)Km値:2.0x10-2±0.5x10-2mM
(グリセロールに対して)、2.0±0.5mM(AT
Pに対して) (3)至適pH:7.5(50mMのPIPES緩衝
液)Then, the centrifuged supernatant was dialyzed against 8 l of 10 mM Tris-hydrochloric acid buffer overnight, and then subjected to Q-sepharose (2 × 8 cm) (Pharmacia) ion exchange chromatography. Elution is 0 to 0 for sodium chloride
Performed with a 0.5 M linear gradient, 0.2-
The 0.3 M sodium chloride elution fraction (110 U) was collected and crude glycerol kinase (110 U, 30 U / m
g) was obtained. Physicochemical properties (1) Enzyme action and substrate specificity: The enzyme action and substrate specificity of this enzyme for glycerol are flavobacterium meningosepticum GK-54 (FERM B
P-4868) strain. (2) Km value: 2.0x10 -2 ± 0.5x10 -2 mM
(For glycerol), 2.0 ± 0.5 mM (AT
(For P) (3) Optimum pH: 7.5 (50 mM PIPES buffer)
【0043】[0043]
【発明の効果】本発明により、熱安定性の良いグリセロ
ールキナーゼおよびその微生物学的製造法を提供できる
ものであり、本酵素を用いるグリセライドやリパーゼ活
性などの測定のための有用かつ熱安定性の良い液状化試
薬を可能とする測定用酵素を提供できた。INDUSTRIAL APPLICABILITY According to the present invention, it is possible to provide a glycerol kinase having a good thermostability and a method for producing a microbe thereof, which is useful for the measurement of glyceride and lipase activity using the present enzyme and has a high thermostability. It was possible to provide a measuring enzyme that enables a good liquefaction reagent.
【図1】図1は本発明のグリセロールキナーゼの至適p
H曲線を示す。FIG. 1 shows the optimum p of the glycerol kinase of the present invention.
The H curve is shown.
【図2】図2は本発明のグリセロールキナーゼのpH安
定曲線を示す。FIG. 2 shows a pH stability curve of the glycerol kinase of the present invention.
【図3】図3は本発明のグリセロールキナーゼの至適温
度曲線を示す。FIG. 3 shows an optimum temperature curve of glycerol kinase of the present invention.
【図4】図4は本発明のグリセロールキナーゼの熱安定
曲線を示す。FIG. 4 shows a thermostable curve of the glycerol kinase of the present invention.
【図5】図5は本発明のグリセロールキナーゼおよびバ
チルス・ステアロサーモフィラス由来グリセロールキナ
ーゼの熱安定曲線を示す。FIG. 5 shows thermostability curves of glycerol kinase of the present invention and glycerol kinase from Bacillus stearothermophilus.
Claims (4)
の活性を保持することを特徴とするグリセロールキナー
ゼ。1. A glycerol kinase which retains an activity of 80% or more after heat treatment at 70 ° C. for 10 minutes.
下、37℃、2週間で80%以上の活性を保持してなる
請求項1記載のグリセロールキナーゼ。2. The glycerol kinase according to claim 1, wherein glycerokinase retains an activity of 80% or more at 37 ° C. for 2 weeks in the absence of a stabilizer.
ールキナーゼ生産菌を培地に培養し、その培養物からグ
リセロールキナーゼを採取することを特徴とするグリセ
ロールキナーゼの製造法。3. A method for producing glycerol kinase, which comprises culturing a glycerol kinase-producing bacterium belonging to the genus Flavobacterium in a medium and collecting glycerol kinase from the culture.
ールキナーゼ生産菌がフラボバクテリウム・メニンゴセ
プティクムGK−54(FERM BP−4868)株
である請求項3記載のグリセロールキナーゼの製造法。4. The method for producing glycerol kinase according to claim 3, wherein the glycerol kinase-producing bacterium belonging to the genus Flavobacterium is Flavobacterium meningosepticum GK-54 (FERM BP-4868) strain.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28042594A JP3649765B2 (en) | 1994-11-15 | 1994-11-15 | Novel glycerol kinase and process for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28042594A JP3649765B2 (en) | 1994-11-15 | 1994-11-15 | Novel glycerol kinase and process for producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH08131165A true JPH08131165A (en) | 1996-05-28 |
| JP3649765B2 JP3649765B2 (en) | 2005-05-18 |
Family
ID=17624879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP28042594A Expired - Fee Related JP3649765B2 (en) | 1994-11-15 | 1994-11-15 | Novel glycerol kinase and process for producing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3649765B2 (en) |
-
1994
- 1994-11-15 JP JP28042594A patent/JP3649765B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP3649765B2 (en) | 2005-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0440990B2 (en) | ||
| US4770997A (en) | Thermostable bilirubin oxidase and production process thereof | |
| US4740465A (en) | Heat-resistant sarcosine oxidase N and process for producing the same | |
| US4902622A (en) | Novel α-1,6-glucosidase and process for producing the same | |
| US4965194A (en) | Pyruvate oxidase and an analytical method using the same | |
| JP3649765B2 (en) | Novel glycerol kinase and process for producing the same | |
| JPS6362195B2 (en) | ||
| JP2984043B2 (en) | Myo-inositol dehydrogenase and method for producing the same | |
| EP0206595B1 (en) | Thermally stable tryptophanase process for producing the same, and thermally stable tryptophanase-producing microorganism | |
| JP2926249B2 (en) | Method for producing alginate lyase | |
| JPH0928375A (en) | Trehalose phosphorylase and its preparation method | |
| US5185257A (en) | Thermostable xanthine oxidase from Arthrobacter luteus | |
| JP3959439B2 (en) | Thermostable trehalase and its production method | |
| JP3602162B2 (en) | Method for producing 3-hydroxybutyrate dehydrogenase | |
| JP3824244B2 (en) | Method for producing cholesterol esterase | |
| JP3781806B2 (en) | Novel pyruvate oxidase, its production method and pyruvate analysis method | |
| KR960007741B1 (en) | Novel(alpha)-1,6-glucosidase and process for producing the same | |
| JPH0638756B2 (en) | Pyruvate assay using pyruvate oxidase and its reagent | |
| JPH0661278B2 (en) | Sensitive method for quantitative determination of myo-inositol and composition for quantitative determination | |
| JPH10127278A (en) | Method for producing cholesterol esterase | |
| JPH07155181A (en) | Novel maltobionic acid glucohydrolase, method for producing the same, reagent for quantifying maltobionic acid using this enzyme, and method for quantifying the same | |
| JPS5813159B2 (en) | Cholesterol Estella Zeomoyl Cholesterol | |
| JPH0561911B2 (en) | ||
| JPS6046953B2 (en) | Improved production method of choline oxidase | |
| JPH0441993B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Effective date: 20040217 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
| A521 | Written amendment |
Effective date: 20040414 Free format text: JAPANESE INTERMEDIATE CODE: A523 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040803 |
|
| A521 | Written amendment |
Effective date: 20040915 Free format text: JAPANESE INTERMEDIATE CODE: A523 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20041207 |
|
| A521 | Written amendment |
Effective date: 20050113 Free format text: JAPANESE INTERMEDIATE CODE: A523 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20050215 |
|
| A61 | First payment of annual fees (during grant procedure) |
Effective date: 20050216 Free format text: JAPANESE INTERMEDIATE CODE: A61 |
|
| R150 | Certificate of patent (=grant) or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 3 Free format text: PAYMENT UNTIL: 20080225 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 4 Free format text: PAYMENT UNTIL: 20090225 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090225 Year of fee payment: 4 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090225 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 5 Free format text: PAYMENT UNTIL: 20100225 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 6 Free format text: PAYMENT UNTIL: 20110225 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110225 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120225 Year of fee payment: 7 |
|
| LAPS | Cancellation because of no payment of annual fees |